Menu
Close
Stories & News
Resources
Stay Informed
x
Stay Informed
February 3, 2023
In 2022, Pfizer continued to strive to enhance shareholder value through development of its innovative R&D pipeline and strategic acquisitions, while maintaining its focus on health equity and environmental stewardship.
As the company looks to build on these initiatives moving forward, here’s a look at some of the key achievements from the past year.
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.